The ATR and ATM checkpoint kinases preserve the integrity of replicating chromosomes by preventing the reversal of stalled and terminal replication forks. Hu et al. now show that the ATR pathway targets the Dna2 nuclease to process stalled forks and counteract fork reversal.
Eukaryotic chromosome replication is tightly controlled to ensure the accurate duplication of genetic information and preservation of genomic integrity. During DNA synthesis, replication fork progression is impeded by DNA topological strain that is magnified in the proximity of transcribed regions or at replication termination (Bermejo et al., 2012) . In response to replication stress induced by DNA damaging agents, replication forks stall in front of DNA lesions and become vulnerable. The positive torsional strain generated when forks pause may contribute to the unwinding of nascent strands from the template, facilitating their annealing and generating fourbranched DNA structures known as reversed forks or ''chicken foot'' structures. In normal cells fork reversal is a very rare event. Reversed forks can be dangerous because they resemble Holliday junctions and may trigger unscheduled homologous recombination events contributing to genomic instability (Branzei and Foiani, 2010) . The ataxia telangiectasia related (ATR) and ataxia telangiectasia mutated (ATM) checkpoint kinases control the stability of replicating chromosomes, thereby preventing fork reversal at stalled and terminal forks (Doksani et al., 2009; Sogo et al., 2002) . In budding yeast, the
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ATR pathway targets the ribonucleotide reductase inhibitor Sml1 and the Mlp1 TPR nucleoporin to respectively facilitate DNA polymerase processivity and simplify the topological context of transcribed chromatin (Bermejo et al., 2012) . These phosphorylation events seem crucial to prevent fork reversal. In this issue of Cell, Hu et al. (2012) (Bae et al., 2001) . Several nucleases participate in the processing of Okazaki fragments at the lagging strand, including Fen1, Rnase HI, and Exo1. Dna2, however, seems specialized in removing long DNA flaps coated by replication protein A (RPA) (Bae et al., 2001) . RPA-singlestranded DNA (ssDNA) nucleofilaments promote activation of the DNA damage checkpoint, and Dna2 at the lagging strand indirectly counteracts the formation of checkpoint signals that otherwise cause an irreversible growth arrest that is checkpoint-dependent (Budd et al., 2011) . Accordingly, in budding yeast, Dna2 becomes dispensable for cell viability, specifically when the checkpoint is defective (Budd et al., 2011) . Dna2 also contributes to the resection of DNA double-strand breaks, thus generating ssDNA tails that engage homologous recombination activities and also promote checkpoint activation (Symington and Gautier, 2011 and references therein) . Hence, Dna2, besides being regulated by the checkpoint machinery, positively and negatively influences the formation of checkpoint signals, depending on the context. Several important questions arise from the study by Hu et al. Are the flap DNA chains originating at stalled forks coated by RPA and do they trigger ATR activation? Previous observations show that in hydroxyurea rad53 CHK2 treated cells (Sogo et al., 2002) , short ssDNA gaps accumulate asymmetrically at the fork branching points. It has been suggested that these ssDNA gaps might originate as a result of the uncoupling of leading and lagging strand synthesis and represent an early step in signaling a stalled fork. An alternative hypothesis, based on the work by Hu et al., is that the first consequence of fork stalling is the formation of flap ssDNA chains, which may promote ATR activation. The asymmetric gaps at the points of fork branching may rather result from Dna2-mediated cleavage of the strands with the nascent flap ( Figure 1 ) and only partially contribute to checkpoint activation. Another relevant issue is whether at stalled forks the chains with nascent flaps result from the processing of Okazaki fragments at the lagging strand or whether they form stochastically at the lagging or the leading strand as a result of topological stress. Hu et al. show that in vitro Dna2 can efficiently cleave regressed leading or lagging strands. We note that besides Dna2, Exo1 has also been implicated in counteracting fork reversal at stalled forks (Cotta-Ramusino et al., 2005) , and the two nucleases act at different steps during Okazaki fragment processing. These observations, together with the finding that the abnormal replication structures accumulated in Rad53 CHK2 defective cells resemble lagging strands defects (Sogo et al., 2002) may suggest that lagging strand synthesis and processing are highly regulated by the checkpoint kinases to prevent aberrant transitions at stalled forks and that the flap DNA strands arise preferentially at the lagging strand. In this scenario, the checkpoint-mediated phosphorylation of Dna2 at stalled forks might have additional implications. In normal cells experiencing replication stress, fork pausing may trigger transient uncoupling between leading and lagging strand synthesis to promote template switching events behind the fork, which are ideal for replicating across a damaged template (Branzei and Foiani, 2010) . The first step of template switching is the annealing of nascent strands, which might be facilitated by a slow mode of lagging replication. Perhaps the checkpointmediated phosphorylation of Dna2 may slow down lagging strand processing, thus contributing to the uncoupling of leading and lagging strand synthesis to provide a window of opportunity for template switching. However, a prolonged arrest of the replication fork would be dangerous as template switching may not be productive, and Dna2 would promote the removal of the flap DNA chains that would otherwise trigger fork reversal (Figure 1) targets (such as Mus81-Eme1 complex, Rqh1, or Rad60) play any roles in preventing fork reversal. Moreover, it would be relevant to address whether Dna2 also acts at terminal forks to prevent fork reversal. In any case, Dna2 plays a key role in maintaining genome stability and the findings by Hu et al. provide a mechanistic framework for the recent observations that human Dna2 enhances cellular tolerance to replication stress and that Dna2 levels are clinically relevant to cancer (Peng et al., 2012) . Models for DNA2-mediated transitions at stalled forks are depicted. Top left: A paused fork is shown in which lagging strand processing is delayed due to Dna2 phosphorylation. A flap DNA chain arises at an Okazaki fragment. The slow lagging processing can trigger template switching events. In an alternate scenario (top right) 5 0 or 3 0 flap DNA strands arise likely due to the topological stress accumulated in the proximity of the fork. In either situation phosphorylated Dna2 could cleave the flap DNA strands, leading to the formation of stable gapped forks, perhaps with the contribution of other nucleases such as Exo1. In contrast, pausing could lead to fork reversal and result in genomic instability.
p53 is a key tumor suppressor protein that has numerous functions. Its primary mode of action has generally been ascribed to the induction of cell-cycle arrest, apoptosis, or senescence upon stress. Li et al. challenge this dogma with evidence that all three of these programs are dispensable for p53's tumor suppressive role.
Over the past 30 years, the p53 tumor suppressor has been subjected to intense scrutiny, with a bewildering and everincreasing number of functions and activities attributed to it. A general consensus has emerged, however, that the key function of p53 in preventing tumor development is the ability to inhibit the outgrowth of inchoate cancers. An elegant and simple model built on numerous studies dictates that many of the stress signals encountered by nascent tumor cells (such as oncogene activation, telomere erosion, hypoxia, and genotoxic damage) lead to the activation of p53, which in turn drives the expression of genes that coordinate programs of three key responses: cellcycle arrest, apoptosis, and senescence (Vousden and Prives, 2009) (Figure 1) . The cell exposed to oncogenic stress is therefore prevented from further proliferation and tumor development avoided.
So the publication of a paper entitled ''Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence'' will cause some excitement and possibly a degree of consternation in the field (Li et al., 2012) . Has all our thinking so far been misled? If these three activities are not required for p53 to suppress tumor development, then what is? Are the other activities of p53-that have so far been thought of rather as support roles-really the key to cancer prevention? Certainly this very interesting study will generate much attention.
p53 is a transcription factor and acts primarily to regulate gene expression. Although much of the regulation of p53 activity is determined by the stability of the p53 protein, a large number of posttranslational modifications on p53 also function to regulate DNA binding and engagement with the transcriptional machinery (Dai and Gu, 2010) . In general, events such as phosphorylation or acetylation on individual sites have rather modest effects on p53 activity, and identifying key modifications that are critical for p53 function has proven to be rather frustrating. Now Li et al. provide evidence that a p53 protein mutated in three of the lysines that are subject to acetylation in the wild-type protein (the 3KR mutant) fails to induce cell-cycle arrest, apoptosis, or senescence in mice (supporting results from the same group showing acetylation is important for these three p53 functions in cells)-but yet retains the ability to protect mice from tumor development.
Maybe this should not be so surprising; indeed several previous studies have hinted that not all these responses are always required (Bieging and Attardi, 2012) . Loss of the primary mediators of p53-induced cell-cycle arrest (p21) or apoptosis (PUMA) clearly do not to lead to tumor susceptibility in the same way as loss of p53. Other p53 mutants that are defective in apoptosis or cell-cycle arrest have been shown to retain tumor suppressor activity (Brady et al., 2011; Liu et al., 2004) , although in these cases at least one of the ''big three'' responses was retained. Intriguingly, the p53-mediated induction of arrest and apoptosis that is seen in the immediate response following irradiation was shown to be irrelevant for suppression of radiationinduced lymphoma (Christophorou et al.,
